Headaches Headaches are the most commonly reported side effect, particularly during the first one to two weeks of use
(PubMed) Leong JY, van der Merwe J, Pepe S, et al
Benchmarking against clinical trials in patients with obesity and type 2 diabetes, semaglutide lowered the risk of heart attack or stroke compared with sitagliptin, as a placebo proxy, showing a hazard ratio (HR) of 0.68
The groundwork for long-term maintenance is in diet, exercise, and behavior change
In C57BL/6J mice, chronic exposure to the fungicide propamocarb induced significant changes in the gut microbial community structures, resulting in a significant increase in TMA levels in the feces (Wu et al., 2018)